BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20250804T171306EDT-402741GO7h@132.216.98.100
DTSTAMP:20250804T211306Z
DESCRIPTION:Treatment guidelines for Guillain-Barré Syndrome (GBS) and Chro
 nic Inflammatory Demyelinating Polyneuropathy (CIDP) were published in 202
 3 and 2021\, respectively. Developed by a team of experts\, these guidelin
 es offer evidence-based recommendations grounded in the latest medical res
 earch and are published in peer-reviewed medical journals.\n	\n	Dr. Mamatha 
 Pasnoor\, Professor of Neurology at the University of Kansas Medical Cente
 r and member of the Global Medical Advisory Board\, specializes in treatin
 g patients with GBS\, CIDP\, and Multifocal Motor Neuropathy (MMN). She al
 so supports patients in accessing clinical trials. In this webinar\, Dr. P
 asnoor will discuss the GBS and CIDP diagnosis and treatment guidelines th
 at inform clinical decision-making. We’ll explore how the guidelines were 
 developed\, how healthcare providers use them\, and highlight key treatmen
 t recommendations.\n\n\n	While MMN-specific guidelines have not been recent
 ly updated and will not be a primary focus of the discussion\, MMN patient
 s and their families may still find value in learning how treatment guidel
 ines are created and applied across related conditions.\n	\n	Who should part
 icipate?\n	\n	GBS and CIDP patients and their families will benefit most fro
 m this discussion\, though healthcare professionals may also find the topi
 c informative. MMN patients may be interested as well\, particularly in un
 derstanding the broader process behind treatment guideline development and
  implementation.\n\nClick here for more information about the 2025 Speaker
  Series\n
DTSTART:20250630T170000Z
DTEND:20250630T180000Z
SUMMARY:Treatment Guidelines for GBS and CIDP: A Patient-Focused Discussion
URL:/infoneuro/channels/event/treatment-guidelines-gbs
 -and-cidp-patient-focused-discussion-365883
END:VEVENT
END:VCALENDAR